Schnell Biopharmaceuticals IncA003060:KSC

584.00
22.00 / 3.63%
7.97m
38.06%
--
Latest price in KRWToday's changeShares traded1 year changeBeta
Data delayed at least 20 minutes, as of Sep 18 2014 16:00 BST.

Summary

As of last trade Schnell Biopharmaceuticals Inc (A003060:KSC) traded at 584.00, 13.74% below its 52-week high of 677.00, set on Sep 12, 2014.

52-week range
Today
379.00
Jul 10 2014
677.00
Sep 12 2014
Markit short selling activity
Low
Medium
High
Open600.00
Day high622.00
Day low574.00
Bid584.00
Offer585.00
Previous close606.00
Average volume17.59m
Shares outstanding143.18m
Free float115.20m
P/E (TTM)--
Market cap83.62bn KRW
EPS (TTM)-81.8077 KRW
Data delayed at least 20 minutes, as of Sep 18 2014 16:00 BST.

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Schnell Biopharmaceuticals Inc-10.57%+19.67%+29.20%+38.06%-56.31%
KOREA SE KOSPI IDX+0.05%-0.97%+5.27%+1.56%+18.50%
Data delayed at least 20 minutes, as of Sep 18 2014 16:00 BST.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.